Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Shuttle Pharmaceuticals Holdings Inc SHPH

Healthcare Biotechnology
Shuttle Pharmaceuticals Holdings, Inc. is a discovery and development stage specialty pharmaceutical company. The Company is focused on improving the outcomes of cancer patients treated with radiation therapy (RT). It is developing a pipeline of products designed to address cancer therapies as well as to extend to the new applications of radiation therapy. Its product candidates include... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:SHPH)

Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering

GlobeNewswire 11 days ago

Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering

GlobeNewswire 12 days ago

Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities

GlobeNewswire 12 days ago

Shuttle Pharma Provides Corporate Update and Reports 2024 Results

GlobeNewswire February 26, 2025

Shuttle Pharma Reaches Milestone in Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

GlobeNewswire January 21, 2025

Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

GlobeNewswire January 7, 2025

Shuttle Pharma Enters into Sponsored Research Agreement with the University of California, San Francisco to Advance PSMA Development Program

GlobeNewswire December 19, 2024

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient

GlobeNewswire November 26, 2024

Shuttle Pharma Provides Third Quarter 2024 Corporate Update

GlobeNewswire November 13, 2024
View More News ››

Opinion & Analysis (NDAQ:SHPH)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:SHPH)

Shuttle Pharma Provides Corporate Update and Reports 2024

Shuttle Pharma’s recent highlights include the following: Accelerated patient enrollment of the Company’s key Phase 2 clinical...
AveragePenny - February 28, 2025

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH): A Disc

https://beyondspx.com/article/shuttle-pharmaceuticals-holdings-inc-nasdaqshph-a-discovery-stage-pharma-innovating-radiation-therapyLLM...
MikeTester - January 23, 2025

Shuttle Pharma Reaches Milestone in Patient Enrollment...

GAITHERSBURG, Md., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a...
AveragePenny - January 22, 2025

Investors Watching Two Small-Caps for News on Potential Majo

JUST IN: $SHPH Investors Watching Two Small-Caps for News on Potential Major Advancements in Cancer Treatments2025-01-13 08:52:56 ET...
whytestocks - January 13, 2025

GROUNDBREAKING CANCER TREATMENT A CONSIDERATION FOR FAMILY..

Strong Data from NIH Sponsored Clinical Trial Suggests Ropidoxuridine Could be Major Advancement for Cancer Patients and Big Win for...
AveragePenny - December 16, 2024

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinic

GAITHERSBURG, Md., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a...
AveragePenny - November 27, 2024
View more Bullboard ››

Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed ...
View More »